Diary - News
All news New project for Adocia
Adocia, a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, today annonced a strategic update and the launch of a new project to develop an innovative formulation of human glucagon.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree